Search results for "Urologia"

showing 10 items of 1005 documents

Five-year prospective study on cardiovascular events, in patients with erectile dysfunction and hypotestosterone.

2017

Objective: Testosterone levels play a role in cardiac and vascular pathology. In the present study we investigated the prognostic significance of this hormone for cardiovascular outcome, in a 5-year follow-up. Materials and methods: Our cohort included 802 adult subjects, from 40 to 80 years. Patients were excluded if they had a past history of peripheral or coronary artery disease, and revascularization. A blood sample was drawn to valuate testosterone level, and we considered normal testosterone levels 300 ng/dl. FMD (flow mediated dilatation) of the brachial artery was assessed by measuring the increase of the brachial artery diameter during reactive hyperemia after transient forearm isc…

AdultMalemedicine.medical_specialtyBrachial ArteryUrologyCardiovascular event030204 cardiovascular system & hematologylcsh:RC870-923Settore MED/24 - UrologiaCardiovascular eventsCoronary artery diseaseCohort Studies03 medical and health sciences0302 clinical medicineErectile DysfunctionRisk Factorsmedicine.arteryInternal medicineSurveys and QuestionnairesmedicineHumansTestosteroneObesityProspective StudiesBrachial arteryProspective cohort studyStrokeReactive hyperemiaAgedDyslipidemiasAged 80 and overbusiness.industryPrevention030208 emergency & critical care medicineTestosterone (patch)Middle Agedlcsh:Diseases of the genitourinary system. Urologymedicine.diseasePrognosisSettore MED/11 - Malattie Dell'Apparato CardiovascolareErectile dysfunctionLogistic ModelsCardiovascular DiseasesCardiologybusinessDyslipidemiaFollow-Up StudiesArchivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
researchProduct

Effects of cerebellar TMS on motor cortex of patient with focal dystonia: a preliminary report

2008

Recent evidence suggests a role for cerebellum in pathophysiology of dystonia. Here we explored, the cerebellar modulation of motor cortex in patients with focal upper limb dystonia. Eight patients and eight controls underwent a transcranial magnetic stimulation protocol to study the cerebellar-brain-inhibition (CBI): a conditioning cerebellar stimulus (CCS) was followed 5 ms after by the contralateral motor cortex stimulation (test stimulus: TS). We explored the effects of CBI on MEP amplitude, short intracortical inhibition (SICI) and intracortical facilitation (ICF) measures. At baseline no differences in TS-MEP amplitude, SICI or ICF were found between patients and controls. Cerebellar-…

AdultMalemedicine.medical_specialtyCerebellumNeurologycerebellummedicine.medical_treatmentStimulus (physiology)Motor ActivitySettore BIO/09 - Fisiologiafocal dystoniamedicineHumansDystoniaAnalysis of Variancebusiness.industryGeneral NeuroscienceMotor CortexNeural InhibitionFocal dystoniaNeurophysiologymedicine.diseaseTranscranial Magnetic StimulationTranscranial magnetic stimulationDystoniamedicine.anatomical_structureTMSArmFemaleSettore MED/26 - Neurologiabusinesshuman activitiesNeuroscienceMotor cortex
researchProduct

Representation of time intervals in the right posterior parietal cortex: implications for a mental time line

2009

Space and time interact with each other in the cognitive system. Recent studies indicate the posterior parietal cortex (PPC) as the neural correlate of spatial-temporal interactions. We studied whether the contribution of the PPC becomes critical in tasks requiring the performance of spatial computations on time intervals. We adopted an integrated neuropsychological and transcranial magnetic stimulation (rTMS) approach, presenting behavioural timing tasks to both healthy subjects and right-brain-damaged patients with and without evidence of spatial neglect. rTMS of the right PPC of healthy subjects induced a lateralised bias during a task requiring setting the midpoint of a time interval. T…

AdultMalemedicine.medical_specialtyCognitive NeuroscienceBisectionmedicine.medical_treatmentPosterior parietal cortexCognitive neuroscienceAudiologyBrain Mapping; Image Interpretation Computer-Assisted; Humans; Adult; Time Perception; Space Perception; Transcranial Magnetic Stimulation; Parietal Lobe; Male; Functional Laterality; Femalebehavioral disciplines and activitiesBrain mappingFunctional LateralityNOComputer-Assisted Image InterpretationComputer-AssistedParietal LobeImage Interpretation Computer-AssistedmedicineSPACEHumansImage InterpretationBrain MappingSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaNeuropsychologyParietal lobeTranscranial Magnetic Stimulation; Computer-Assisted Image Interpretation; Time Perception; Space Perception; Parietal Lobe; Functional Laterality; Brain MappingTime perceptionTranscranial Magnetic StimulationTIMETranscranial magnetic stimulationNeurologyNEGLECTTMSSpace PerceptionTime PerceptionFemaleSettore MED/26 - NeurologiaPsychologypsychological phenomena and processesHumanCognitive psychology
researchProduct

Perceiving numbers alters time perception.

2008

The representation of time, space and numbers are strictly linked in the primate's cognitive system. Here we show that merely looking at number symbols biases a temporal judgment on their duration depending upon the number's magnitude. In a first experiment, a group of healthy subjects was submitted to a time estimation task, requiring to judge whether the duration of a test stimulus was longer or shorter than that of a previous reference fixed stimulus (digit 5; duration 300 ms). Test stimuli were the digits 1, 5 and 9 ranging between 250 and 350 ms. The main results showed that temporal perception was biased according to the magnitude expressed by the digit: low digits (i.e. 1) leading to…

AdultMalemedicine.medical_specialtyCognitive systemsTime Factorsmedia_common.quotation_subjectAudiologyStimulus (physiology)Developmental psychologyNOTime estimationPerceptionmedicineHumansmedia_commonAnalysis of VarianceGeneral NeuroscienceHealthy subjectsTime perception numbers magnitudeTime perceptionPhotic Stimulation; Analysis of Variance; Humans; Adult; Time Perception; Time Factors; Male; Female; MathematicsNumerical digitTime PerceptionMagnitude Numbers Time perception Adult Analysis of Variance Female Humans Male Photic Stimulation Time Factors Time Perception Mathematics Neuroscience (all)Settore MED/26 - NeurologiaFemaleAlphabetPsychologyMathematicsPhotic StimulationNeuroscience letters
researchProduct

Expression patterns and prognostic role of transketolase-like 1 in muscle-invasive bladder cancer

2015

PURPOSE: The pentose phosphate pathway (PPP) has been shown to play an important role in the metabolism of cancer cells. The transketolase-like 1 gene (TKTL1) encodes an enzyme representing an essential component of this pathway. Its expression has been demonstrated to correlate with stage and outcome in various tumors. The aim of the present study was to assess expression patterns and the prognostic role of TKTL1 in muscle-invasive bladder cancer (MIBC). PATIENTS AND METHODS: The expression of TKTL1 was assessed in a tissue microarray consisting of histopathologically benign and malign tissue of 112 patients who underwent radical cystectomy due to MIBC. Cytoplasmatic and nuclear expression…

AdultMalemedicine.medical_specialtyGlycolysiUrologymedicine.medical_treatmentBiopsyDiabetePentose phosphateSettore MED/24 - UrologiaCystectomyInternal medicineBiopsymedicineHumansNeoplasm InvasivenessUrotheliumLymph nodeAgedRetrospective StudiesAged 80 and overBladder cancerTissue microarraymedicine.diagnostic_testbusiness.industryBladder cancerTransketolase-like 1DNA NeoplasmBiomarkerMiddle Agedmedicine.diseaseImmunohistochemistryGene Expression Regulation Neoplasticmedicine.anatomical_structureEndocrinologyUrinary Bladder NeoplasmsTissue Array AnalysisCancer cellCancer researchImmunohistochemistryFemaleTransketolaseUrotheliumbusinessFollow-Up Studies
researchProduct

Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study.

2014

Objective: The objective of this paper is to identify clinical or magnetic resonance imaging (MRI) predictors of long-term clinical progression in a large cohort of multiple sclerosis (MS) patients. Methods: A total of 241 relapsing–remitting (RR) MS patients were included in a nine-year follow-up (FU) study. The reference MRIs were acquired at baseline (BL) as part of a multicenter, cross-sectional, clinical-MRI study. Volumetric MRI metrics were measured by a fully automated, operator-independent, multi-parametric segmentation method. Clinical progression was evaluated as defined by: conversion from RR to secondary progressive (SP) disease course; progression of Expanded Disability Status…

AdultMalemedicine.medical_specialtyMagnetic resonance imaging follow-up multiple sclerosis clinical predictors gray matter atrophypredictormultiple sclerosisDisease courseDisability EvaluationMultiple Sclerosis Relapsing-RemittingInternal medicinefollow-upmedicineHumansSecondary progressiveExpanded Disability Status Scalemedicine.diagnostic_testbusiness.industryMultiple sclerosisDisease progressionFollow up studiesMagnetic resonance imagingclinical predictorsMiddle Agedmedicine.diseaseMagnetic Resonance Imaginggray matter atrophyCross-Sectional StudiesNeurologymultiple sclerosiDisease ProgressionSettore MED/26 - NeurologiaFemaleNeurology (clinical)businessNuclear medicineClinical progressionMRIFollow-Up StudiesMultiple sclerosis (Houndmills, Basingstoke, England)
researchProduct

Prevalence and incidence of multiple sclerosis in the city of Monreale, Italy

1997

The prevalence and incidence of multiple sclerosis (MS) in the city of Monreale, southern Italy were ascertained 10 years after a preliminary study in the same area. The study was undertaken in a population of 26,256 people. The patients were classified according to Poser’s criteria. The prevalence of MS on 31 December 1991 was 72.4 per 100,000 population. The incidence of MS for the period 1981–1991 was 3.3/100,000 per year. The mean period between onset and diagnosis of MS was 4.9 years for those patients found during this survey and 9.2 years for those in the first study. This study shows an increase of MS prevalence in Monreale city and a high incidence. The findings parallel the reduct…

AdultMalemedicine.medical_specialtyMultiple SclerosisAdolescentEpidemiologyPopulationAge DistributionLag timeEpidemiologyPrevalencemedicineHumansMultiple sclerosiSex DistributionChildeducationAgededucation.field_of_studybusiness.industryIncidenceMultiple sclerosisIncidence (epidemiology)Infant NewbornInfantMiddle Agedmedicine.diseaseHealth SurveysItalyNeurologyChild PreschoolSettore MED/26 - NeurologiaFemaleNeurology (clinical)businessDemographyJournal of Neurology
researchProduct

Blood lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients

2009

Abstract Multiple Sclerosis (MS) patients present a decrease of antioxidants and neuroprotective and immunoregulatory vitamins and an increase of total homocysteine (tHcy), cholesterol (CHL), HDL-cholesterol, and of cellular stress markers, variably associated with the different phases of the disease. We compared the blood levels of uric acid, folic acid, vitamins B12, A, and E, tHcy, CHL, HDL-cholesterol, and triglycerides in forty MS patients during a phase of clinical inactivity with those of eighty healthy controls, matched for age and sex. We found higher levels of tHcy (p = 0.032) and of HDL-cholesterol (p = 0.001) and lower levels of vitamin E (p = 0.001) and the ratio vitamin E/CHL …

AdultMalemedicine.medical_specialtyMultiple SclerosisAdolescentHomocysteineEndocrinology Diabetes and Metabolismmedicine.medical_treatmentClinical BiochemistryBlood lipidsClinical nutritionBiologyAntioxidantschemistry.chemical_compoundFolic AcidEndocrinologyHigh-density lipoproteinSettore BIO/10 - BiochimicaInternal medicinemedicineHumansShort PaperVitamin B12Homocysteinelcsh:RC620-627TriglyceridesBiochemistry medicalCholesterolVitamin EBiochemistry (medical)VitaminsMiddle AgedLipidsUric Acidlcsh:Nutritional diseases. Deficiency diseasesEndocrinologychemistryCase-Control StudiesUric acidSettore MED/26 - NeurologiaFemalelipids (amino acids peptides and proteins)Lipids in Health and Disease
researchProduct

High Prevalence and Fast Rising Incidence of Multiple Sclerosis in Caltanissetta, Sicily, Southern Italy

2006

<i>Background:</i> Epidemiological studies conducted in Sicily and Sardinia, the two major Mediterranean islands, showed elevated incidence and prevalence of multiple sclerosis (MS)and a recent increase in disease frequency. <i>Objective:</i> To confirm the central highlands of Sicily as areas of increasing MS prevalence and elevated incidence, we performed a follow-up study based on the town of Caltanissetta (Sicily), southern Italy. <i>Methods:</i> We made a formal diagnostic reappraisal of all living patients found in the previous study performed in 1981. All possible information sources were used to search for patients affected by MS diagnosed accordi…

AdultMalemedicine.medical_specialtyMultiple SclerosisAdolescentMultiple sclerosis incidence Prevalence SicilyEpidemiologyAge DistributionEpidemiologyPrevalencemedicineHumansSex DistributionSicilyAgedHigh prevalencebusiness.industryIncidenceMultiple sclerosisIncidence (epidemiology)Urban HealthMiddle Agedmedicine.diseaseHealth SurveyshumanitiesFemaleSettore MED/26 - NeurologiaNeurology (clinical)businessMediterranean IslandsFollow-Up StudiesDemographyNeuroepidemiology
researchProduct

Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center

2020

Abstract Background Alemtuzumab, is a compound approved for highly active MS, and, in Europe, employed after the use of other disease-modifying treatments (DMTs) with an escalation approach or used as a first therapeutic option. The occurrence of secondary autoimmune adverse events and or infections can differ depending on the employed approach. Objective To evaluate the efficacy and safety of alemtuzumab in real-world MS population that encompassed patients previously treated with other DMTs. Methods 35 patients, treated with alemtuzumab in a single MS Center, were followed for at least 36 months. The study investigated the prevalence of patients reaching the phase of the non-active diseas…

AdultMalemedicine.medical_specialtyMultiple SclerosisEfficacyPopulationDisease03 medical and health sciences0302 clinical medicineInternal medicinePost-hoc analysisOutcome Assessment Health CaremedicineHumansImmunologic Factors030212 general & internal medicineAdverse effecteducationAlemtuzumabeducation.field_of_studybusiness.industryMultiple sclerosisGeneral MedicineMiddle Agedmedicine.diseasePancytopeniaProgression-Free SurvivalNeurologyItalyAdverse eventsDisease ProgressionAlemtuzumabFemaleSettore MED/26 - NeurologiaNeurology (clinical)Autoimmune hemolytic anemiaSafetybusiness030217 neurology & neurosurgerymedicine.drugFollow-Up Studies
researchProduct